Improving Insulin Therapy With Enhanced Care Management
1 other identifier
interventional
244
1 country
1
Brief Summary
VA diabetes patients often have difficulty managing their self-care and accessing clinic-based services; many also lack social support to help them meet the demands of their illness. Enhanced support is especially important when undertaking and sustaining new challenging self-care tasks, such as initiating or intensifying insulin treatment regimens. Although some VAs have implemented telephone nurse care management programs supported by automated calling services, many are reluctant to adopt these models due to nursing shortages.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3 diabetes
Started Feb 2007
Longer than P75 for phase_3 diabetes
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 27, 2006
CompletedFirst Posted
Study publicly available on registry
May 3, 2006
CompletedStudy Start
First participant enrolled
February 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2010
CompletedResults Posted
Study results publicly available
November 10, 2014
CompletedApril 24, 2015
August 1, 2014
2.7 years
April 27, 2006
September 19, 2014
April 6, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Glycemic Control (HbA1c)
The primary outcome was change between baseline and six-month Hemoglobin A1c (HbA1c), measured with a Bayer DCA 2000+ point-of-care analyzer.
6 months (baseline to 6 months)
Secondary Outcomes (3)
Change in Systolic Blood Pressure Measure
change in blood pressure at 6 months
Change in Diastolic Blood Pressure
6 months from baseline
Number of Participants With Insulin Starts at 6 Months
6 months (baseline to 6 months follow-up)
Study Arms (2)
Reciprocal Diabetes Peer Support program
EXPERIMENTALpeers are paired during the group visit and are encouraged to speak with their partner at least once a week for the 6 month duration of the study.
Nurse Case Management
OTHERpatients are not paired in the NCM arm. they are provided with educational session on diabetes management and informed of case management services.
Interventions
participants are paired with another age-matched participation. Paired peer partners were encouraged to talk weekly using a telephone platform that recorded call frequency and duration and provided automated reminders promoting peer contact.
patients are not paired in the NCM arm attended a 1.5 hour session to receive education on care manager services and diabetes educational materials and be assigned to a nurse care manager with whom they were encouraged to follow-up regularly.
Participants in the peer group were also offered three optional 1.5 hour patient-driven group sessions at month 1, 3, and 6
Eligibility Criteria
You may qualify if:
- type 2 diabetes
- HbA1c \> 7%
- age \> 21
You may not qualify if:
- substance abuse disorder
- serious psychiatric illness
- serious hearing loss
- life expectancy \< 12 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
VA Ann Arbor Healthcare System, Ann Arbor, MI
Ann Arbor, Michigan, 48105, United States
Related Publications (1)
Heisler M, Vijan S, Makki F, Piette JD. Diabetes control with reciprocal peer support versus nurse care management: a randomized trial. Ann Intern Med. 2010 Oct 19;153(8):507-15. doi: 10.7326/0003-4819-153-8-201010190-00007.
PMID: 20956707RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
1. study only included male patients. 2. intervention only lasted six months. 3. the nature of the intervention prevented blinding to treatment group. 4. A final limitation is the relatively low rate of uptake of the intervention.
Results Point of Contact
- Title
- Fatima Makki
- Organization
- VA HSRD
Study Officials
- PRINCIPAL INVESTIGATOR
John D. Piette, PhD
VA Ann Arbor Healthcare System, Ann Arbor, MI
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 27, 2006
First Posted
May 3, 2006
Study Start
February 1, 2007
Primary Completion
October 1, 2009
Study Completion
March 1, 2010
Last Updated
April 24, 2015
Results First Posted
November 10, 2014
Record last verified: 2014-08